In focus
Latest feed
Roivant’s Lung‑Targeted Therapy Nails Phase 2 Goal, Shares Jump to Record Levels
Welspun Corp Rockets on Historic $1.8 Billion US Order: A New Chapter Unfolds!
Roche's Remarkable Rally: Diving into H1 2026 Performance and the Market's Surprising Enthusiasm
SpaceX Shares Surge 30% and Slip Into America’s Top‑Six Valued Companies